Cystic Fibrosis Therapeutics Development Network

The Cystic Fibrosis Therapeutics Development Network (CF TDN) is a collaborative research initiative focused on developing and testing new treatments for cystic fibrosis, a genetic disease affecting the lungs and digestive system. It brings together experts, clinics, and patients to conduct clinical trials efficiently and safely. By sharing knowledge and resources, the network aims to accelerate the discovery of effective therapies, improve patient outcomes, and advance personalized medicine for those living with cystic fibrosis.